Skip to Main Content

Paper Details

Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Expert Rev Pharmacoecon Outcomes Res
1
2023
Author NameAffiliation
Amanda Pereira-Salgadothe University of Melbourne
Amanda Pereira-SalgadoUniversity of Melbourne
Arun A AzadPeter MacCallum Cancer Centre
Maarten J IJzermanthe University of Melbourne
Maarten J IJzermanUniversity of Melbourne
Maarten J IJzermanPeter MacCallum Cancer Centre
  • 1 - 6

Datasets

Release 1.2